The Prowess of Andrographolide as a Natural Weapon in the War against Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Prowess of Andrographolide as a Natural Weapon in the War against Cancer
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2159
Publisher
MDPI AG
Online
2020-08-04
DOI
10.3390/cancers12082159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients
- (2020) Annika Fendler et al. Nature Communications
- Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology
- (2019) Carlota Recio et al. ONCOGENE
- Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
- (2019) Gloria V. Echeverria et al. Science Translational Medicine
- Andrographolide antagonizes the cigarette smoke-induced epithelial-mesenchymal transition and pulmonary dysfunction through anti-inflammatory inhibiting HOTAIR
- (2019) Haibo Xia et al. TOXICOLOGY
- Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells
- (2019) Sreeharsha Gurrapu et al. Science Signaling
- Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling
- (2019) Rachel Eyre et al. Nature Communications
- Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis
- (2018) Xin-Shi Zhang et al. ASIAN JOURNAL OF ANDROLOGY
- A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer
- (2018) Somrudee Reabroi et al. BIOMEDICINE & PHARMACOTHERAPY
- PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
- (2018) Hsi-Wen Yeh et al. NATURE CELL BIOLOGY
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
- (2018) Kenneth KW To et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer
- (2018) Virginia Murillo-Garzón et al. Nature Communications
- The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells
- (2018) Somrudee Reabroi et al. Scientific Reports
- Andrographolide enhances redox status of liver cells by regulating microRNA expression
- (2018) Swati Khole et al. FREE RADICAL BIOLOGY AND MEDICINE
- Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway
- (2017) Jianwei Dai et al. International Journal of Biological Sciences
- Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis
- (2017) Huan-Tian Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Diterpenes and Their Derivatives as Potential Anticancer Agents
- (2017) Muhammad Torequl Islam PHYTOTHERAPY RESEARCH
- In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis
- (2017) Wei Yang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway
- (2017) Rui Zhang et al. Oncology Letters
- Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells
- (2017) Aditi Banerjee et al. Oncotarget
- MicroRNA-targeted therapeutics for lung cancer treatment
- (2016) Jing Xue et al. Expert Opinion on Drug Discovery
- SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development
- (2016) X Shi et al. ONCOGENE
- Plant metabolism, the diverse chemistry set of the future
- (2016) E. T. Wurtzel et al. SCIENCE
- Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway
- (2016) Shanwei Mi et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation
- (2016) Po-Yu Yang et al. Oncotarget
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway
- (2015) HUI GAO et al. Molecular Medicine Reports
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway
- (2015) Deepak Kumar et al. PLoS One
- Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth
- (2015) Jie Li et al. OncoTargets and Therapy
- Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
- (2014) Wenjie Guo et al. Autophagy
- Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
- (2014) Zanjing Zhai et al. BREAST CANCER RESEARCH AND TREATMENT
- Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade
- (2014) Kaikai Shen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathway
- (2014) Qian-Qian Zhang et al. MELANOMA RESEARCH
- Antitumor Activity of Monoterpenes Found in Essential Oils
- (2014) Marianna Vieira Sobral et al. TheScientificWorldJOURNAL
- A Review on Anti-Inflammatory Activity of Monoterpenes
- (2013) Rita de Cássia da Silveira e Sá et al. MOLECULES
- Therapeutic modulators of STAT signalling for human diseases
- (2013) Gabriella Miklossy et al. NATURE REVIEWS DRUG DISCOVERY
- Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer
- (2013) Guo-Qing Bao et al. TOXICOLOGY LETTERS
- A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway
- (2013) Gong BioScience Trends
- The complex world of WNT receptor signalling
- (2012) Christof Niehrs NATURE REVIEWS MOLECULAR CELL BIOLOGY
- On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
- (2012) L Y Dimberg et al. ONCOGENE
- Mining the Biodiversity of Plants: A Revolution in the Making
- (2012) V. De Luca et al. SCIENCE
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide RNAi Screen Reveals Disease-Associated Genes That Are Common to Hedgehog and Wnt Signaling
- (2011) L. S. Jacob et al. Science Signaling
- Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab
- (2010) H. M. Stern et al. CLINICAL CANCER RESEARCH
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin
- (2009) Jing Zhou et al. BIOCHEMICAL PHARMACOLOGY
- Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer
- (2009) J M Bailey et al. ONCOGENE
- Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation
- (2008) J. Zhou et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now